Definitive Contract N6833524C0308
Award Date
7/15/24
Potential Completion Date
8/25/25
Potential Value
$246K
Funding Federal Agency
Office of Naval Research
Contracting Federal Agency
Naval Air Warfare Center
Awardee
Emergingdx Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mansfield, MA 02048, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
STTR Phase I
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project from the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract, valued at $249,993.61, supports the development of a "Rapid, Automated, Multiplexed Omics Platform" for medical research and diagnostic applications. As a total small business set-aside contract, this award demonstrates Emergingdx Inc.'s expertise...
This is a firm fixed price SBIR Phase I contract awarded by the Department of the Navy Secretary of the Navy Office of Naval Research to Emergingdx Inc., a for-profit subchapter S corporation. The $239,636.00 contract funds research under the SBIR Program to advance disease detection and precision medicine capabilities. Emergingdx Inc. has also received several other recent SBIR and STTR Phase I awards from the Defense Health Agency and Department of Agriculture to develop biosensors, microRNA...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
Emergingdx Inc. was awarded a $249,837 firm fixed price Small Business Technology Transfer (STTR) Phase I contract by the Defense Health Agency (DHA) to develop a multiplexed biosensor for rapid detection of a multi-omics biomarker panel. The research will be conducted over a seven-month period ending in May 2024 at Emergingdx's facility in Mansfield, Massachusetts. The contract has a total small business set aside designation. The DHA oversees medical research and development programs within...
The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
The U.S. Defense Health Agency (DHA) awarded a Small Business Technology Transfer (STTR) Phase II contract to Emergingdx Inc., a small business subchapter S corporation based in Lowell, Massachusetts. The $1,299,985.23 Firm Fixed Price contract, which is set aside for total small business, supports the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." This contract builds upon earlier SBIR Phase I exploratory research and aims to advance innovative...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a for-profit subchapter S corporation based in Mansfield, Massachusetts. The $249,998.68 firm-fixed-price contract is for the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." Emergingdx is a company focused on developing diagnostic and biosensor technologies, with an emphasis on disease detection and precision medicine...
This is a STTR Phase II award from the Department of the Army Materiel Command Research Development and Engineering Command to Sensodx II, LLC, a self-certified small disadvantaged business. The $999,998.24 firm fixed price contract is for the development of Sensodx's Programmable Bio-Nano-Chip (p-BNC) technology to detect a wider range of illicit drugs in the field. New York University is a subcontractor on the project, which aims to expand the number of detectable drugs and adapt the...
This is a Small Business Innovation Research (STTR) Phase I contract awarded by the Defense Health Agency to Innosense Corporation, a minority-owned, economically disadvantaged women-owned small business. The $162,499.11 fixed-price contract is for research and development on a multi-functional nanotube-based sensor array to detect blood coagulation defects. The research aims to advance medical diagnostic capabilities relevant to the Defense Health Agency's mission. Innosense has a history of...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...